Tango Therapeutics, Inc.TNGXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank67
3Y CAGR+48.7%
5Y CAGR+111.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+48.7%/yr
Annual compound
5Y CAGR
+111.7%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
42.5x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$9.70M-37.4%
2024$15.50M+23.4%
2023$12.56M+326.0%
2022$2.95M+1093.9%
2021$247000.00+8.3%
2020$228000.00-78.6%
2019$1.07M-